DEANNA BREWER: Open Payments
NPI 1679827786 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 11 payments from 6 companies in 2025. Trend: 2023 $164 · 2024 $203 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $63 |
| La Jolla Pharmaceutical Company | 2 | $55 |
| Merck Sharp & Dohme LLC | 2 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| Baxter Healthcare | 1 | $32 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
Products named: GIAPREZA, ZERBAXA, XIFAXAN, AVYCAZ, PERCLOT, Exparel, TEFLARO.
Industry payments across TX — which companies pay providers there.
